🇺🇸 FDA
Patent

US 8541185

Method of predicting responsiveness to autologous adoptive cell transfer therapy

granted A61PA61P35/00

Quick answer

US patent 8541185 (Method of predicting responsiveness to autologous adoptive cell transfer therapy) held by TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. expires Mon Sep 19 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD.
Grant date
Tue Sep 24 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 19 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61P, A61P35/00